The Indian pharmaceutical sector is undergoing a significant transformation in 2026, driven by landmark regulatory reforms from the Central Drugs Standard Control Organization (CDSCO), new clinical trial fast-track rules, updated…
India, known as the "Pharmacy of the World," supplies over 20% of the global generic medicine market by volume. But with this position comes a critical responsibility — maintaining rigorous…
The United States Food and Drug Administration (USFDA) has approached Indian pharmaceutical manufacturers to address a critical shortage of ifosfamide, a chemotherapy drug essential for treating testicular cancer, lung cancer,…
India’s pharmaceutical industry supplies roughly 40 percent of the United States’ generic medicines and approximately 20 percent of global demand. Yet behind this impressive export footprint lies a structural vulnerability…